SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-134627
Filing Date
2014-04-08
Accepted
2014-04-08 09:23:59
Documents
5
Period of Report
2014-04-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d707755d8k.htm 8-K 18599
2 EX-10.1 d707755dex101.htm EX-10.1 20040
3 EX-99.1 d707755dex991.htm EX-99.1 7896
4 GRAPHIC g707755707755image.jpg GRAPHIC 11764
5 GRAPHIC g707755new707755image.jpg GRAPHIC 8352
  Complete submission text file 0001193125-14-134627.txt   75903
Mailing Address 11975 EL CAMINO REAL SUITE 101 SAN DIEGO CA 92130
Business Address 11975 EL CAMINO REAL SUITE 101 SAN DIEGO CA 92130 858-792-6300
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-50484 | Film No.: 14750068
SIC: 2834 Pharmaceutical Preparations